Skip to main content
3.145.151.7

Tags: regulatory incentives

Peer-reviewed journal (1-1 of 1)

  1. Why We Need Continuous Pharmaceutical Manufacturing and How to Make It Happen

    Contributor(s):: Clive Badman, Charles L.Cooney, Alastair Florence, Konstantin Konstantinov, Markus Krumme, Salvatore Mascia, Moheb Nasr, Bernhardt L. Trout

    We make the case for why continuous pharmaceutical manufacturing is essential, what the barriers are, and how to overcome them. To overcome them, government action is needed in terms of tax incentives or regulatory incentives that affect time.